CD160 and Crohn disease: Another study by Bouma et al. revealed that Thiopurine treatment reduced the expression of CD160 in whole blood of Crohn's disease patients, and thiopurine might produce its effect by selectively affecting effector cytotoxic CD160-positive cells (78).